Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS Rector takes three months sabbatical leave
2008-05-05

The Rector of the University of the Free State (UFS), Prof. Frederick Fourie, has announced that he will be taking three months sabbatical leave as from Thursday, 8 May 2008.

Prof. Fourie recently made the request for sabbatical leave to the Chairperson of the UFS Council, Judge Faan Hancke. The request was approved given the fact that Prof. Fourie has occupied a number of demanding top-management posts for almost nine years, during which time he had to manage a number of major changes at the UFS.

According to Prof. Fourie, he originally wanted to go on sabbatical leave in the second half of 2007 before the start of his second term as rector, but it was not possible at that stage.

He was last on sabbatical in 1996 before he became Dean of the Faculty of Economic and Management Sciences in 1997 and Vice-Rector: Academic Operations in 1999.

He could not take his next five-yearly leave because in the post of vice-rector he was tasked with leading the financial-turnaround strategy for the UFS from the year 2000 and had to act as rector when the previous rector, Prof. Stef Coetzee, was on sick leave. Since being inaugurated as rector in 2003, there was also no opportunity to take leave as a result of the many key projects and urgent initiatives.

The Vice-Rector: Academic Operations and vice-chairperson of the Senate, Prof. Teuns Verschoor, will be the acting rector. Management processes and decision-making will continue as normal under the leadership of the acting rector together with the Executive Committee of the Executive Management (Exco) and the Executive Management. This applies to the decision about the future of the Reitz Residence as well as the continuing implementation of the policy on diversity in student residences.

According to Judge Hancke it was important that Prof. Fourie took sabbatical leave in the light of the long period he has been at the forefront of very demanding changes. There are many challenges that still lie ahead.

During his leave Prof. Fourie will be involved with the Higher Education South Africa (HESA) investigation into diversity and racism on campuses, with research and a national conference on institutional culture, as well as the Association of Commonwealth Universities (ACU) benchmarking project and its conference in Australia at the end of August 2008.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept